EssilorLuxottica to Acquire European Ophthalmology Network Optegra Clinics
EssilorLuxottica and MidEuropa have entered into an agreement in which EssilorLuxottica will acquire Optegra, an integrated ophthalmology platform operating in five European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands.
Financial terms of the deal were not disclosed.
"The acquisition represents a significant milestone in EssilorLuxottica’s med-tech strategy, building on the group’s offering which today spans far beyond frames and lenses to include AI-powered innovative technologies, wearables, medical instruments and science-backed eyecare solutions that improve the lives of millions of people," EssilorLuxottica stated in a news release.
The Optegra group, under the Optegra, Lexum and Iris brands, operates an network of over 70 eye hospitals and diagnostic facilities across Europe, offering medically necessary ophthalmic treatments and elective vision correction procedures supported by AI in pre- and post-op stages.
“With the acquisition of Optegra, we are stepping into a new frontier—one where comprehensive eye care, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform," Francesco Milleri, Chairman and Chief Executive Officer, and Paul du Saillant, Deputy Chief Executive Officer at EssilorLuxottica, said in a company news release. "We have the strategic assets to fuel this vision: an extensive distribution network with new clinical approaches, a smart eyewear offering with healthcare potential, and diagnostic capabilities that will be able to detect conditions ranging from neurodegenerative diseases to cardiovascular dysfunction. Optegra and its experienced doctors will bring new medical capabilities to our group, enabling us to address patients’ needs with the most advanced vision care technologies and treatments in one trusted system that will anchor our med-tech aspirations. Powered by our growing AI and big data capabilities, we will be able to broaden our impact and deliver the most personalized and seamless patient journey,” said Dr. Peter Byloos, Chief Executive Officer of Optegra Eye Health Care. “Joining forces with EssilorLuxottica marks a transformative chapter for Optegra. Their global leadership in vision care, combined with our clinical excellence and patient-centric approach, creates an innovative platform to redefine the paradigm of ophthalmic services."
The transaction is expected to close later in 2025 pending regulatory approvals and other customary closing conditions.